Raising the bar: can Gilead’s next challenge be even bigger than Hep C?How do you follow a genuine drug breakthrough, a cure for hepatitis C? Andrew McConaghie visits Gilead’s headquarters Share XRaising the bar: can Gilead’s next challenge be even bigger than Hep C?https://pharmaphorum.com/views-and-analysis/raising-the-bar-can-gilead-s-next-challenge-be-even-bigger-than-hep-c/
NICE calls the shots on Harvoni – but NHS England eyeing price controlsHarvoni and rival hep C drugs look set for approval in England – but NHS England may have Share XNICE calls the shots on Harvoni – but NHS England eyeing price controlshttps://pharmaphorum.com/views-and-analysis/nice-calls-the-shots-on-harvoni-but-nhse-eyeing-price-controls/
